| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 724058 | 3-[(N,N-Dimethylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-8 ,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline | 0.00714731931708452 | 0.46656328 |
| NSC 725670 | 5,6-Dihydro-5,11-dioxo-6-(2-N-piperazine-1-ethyl)-11H-indeno [1,2-c]isoquinoline | 0.00714731931708452 | 0.26222018 |
| NSC 733465 | Null | 0.00714731931708452 | 0.51936968 |
| NSC 752461 | Null | 0.00714731931708452 | 0.30119145 |
| NSC 117281 | ANTINEOPLASTIC-117281 | 0.00770426557728501 | 0.50525161 |
| NSC 236657 | Cyclopent[v][1,12]oxaazacyclotetracosine-1,14(11H,22aH) -dione, 12,13,23,24-tetrahydro-23,25-dihydroxy- 24-methoxy-3,22a-dimethyl-12-phenyl- (9CI) | 0.00770426557728501 | 0.19929972 |
| NSC 2805 | 2,2',5,5'-Tetrahydroxy-4,4'-dimethylbiphenyl | 0.00770426557728501 | 0.69060891 |
| NSC 321206 | Null | 0.00770426557728501 | 0.56828688 |
| NSC 363143 | Stannane, dichlorodiphenyl-, compd. with 1,4,7,10,13,16-hexaoxacyclooctadecane (1:1) | 0.00770426557728501 | 0.45174574 |
| NSC 603086 | 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (Z)- | 0.00770426557728501 | 0.78380858 |